Abstract
058. The Efficacy and Safety of Subcutaneous Tocilizumab Versus Intravenous Tocilizumab in Combination with Traditional DMARDs in Patients with RA at Week 97: Results from the Summacta Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have